Sara Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 11-12-2024
- Paid Up Capital ₹ 1.50 M
as on 11-12-2024
- Company Age 17 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.01 M
as on 11-12-2024
- Satisfied Charges ₹ 1.34 Cr
as on 11-12-2024
- Revenue 76.22%
(FY 2022)
- Profit 63.79%
(FY 2022)
- Ebitda 14.47%
(FY 2022)
- Net Worth 81.39%
(FY 2022)
- Total Assets -17.82%
(FY 2022)
About Sara Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹9.01 M. The company has closed loans amounting to ₹1.34 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sangeeta Aggarwal, Naval Aggarwal, and Ravinder Aggarwal serve as directors at the Company.
- CIN/LLPIN
U24232CH2007PTC030831
- Company No.
030831
- Incorporation Date
28 May 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sara Remedies Limited offer?
Sara Remedies Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Cardiovascular Drugs & Medication, Kidney Drugs, Antacid Drugs, Pain Relief Drugs & Pharmaceuticals, Antipyretic Medication, Anti Infective Drugs & Medicines.
Who are the key members and board of directors at Sara Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sangeeta Aggarwal  | Director | 28-May-2007 | Current |
| Naval Aggarwal | Director | 28-May-2007 | Current |
| Ravinder Aggarwal | Director | 28-May-2007 | Current |
Financial Performance of Sara Remedies.
Sara Remedies Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 76.22% increase. The company also saw a substantial improvement in profitability, with a 63.79% increase in profit. The company's net worth Soared by an impressive increase of 81.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sara Remedies?
In 2020, Sara Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
B.B.N. Infosystem Private LimitedActive 13 years 3 monthsNaval Aggarwal and Ravinder Aggarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 21 Jan 2023 | ₹1.51 M | Open |
Allahabad Bank Creation Date: 29 Dec 2014 | ₹2.50 M | Open |
Allahabad Bank Creation Date: 25 Sep 2013 | ₹5.00 M | Open |
How Many Employees Work at Sara Remedies?
Unlock and access historical data on people associated with Sara Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sara Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sara Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
